<?xml version="1.0" encoding="UTF-8"?>
<ref id="B2-pharmaceutics-13-00379">
 <label>2.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Winblad</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Amouyel</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Andrieu</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Ballard</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Brayne</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Brodaty</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Cedazo-Minguez</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Dubois</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Edvardsson</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Feldman</surname>
    <given-names>H.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Defeating Alzheimerâ€™s disease and other dementias: A priority for European science and society</article-title>
  <source>Lancet Neurol.</source>
  <year>2016</year>
  <volume>15</volume>
  <fpage>455</fpage>
  <lpage>532</lpage>
  <pub-id pub-id-type="doi">10.1016/S1474-4422(16)00062-4</pub-id>
  <pub-id pub-id-type="pmid">26987701</pub-id>
 </element-citation>
</ref>
